Differential expression of functionally identified and immunohistochemically identified NK(1) receptors on sympathetic neurons.
We have used multiple-labeling immunohistochemistry, intracellular dye-filling, and intracellular microelectrode recordings to characterize the distribution of tachykinin receptors and substance P boutons on subpopulations of neurons within the guinea pig celiac ganglion. Superfusion of substance P (SP, 1 microM for 1 min) depolarized 42% of tonic neurons and inhibited afterhyperpolarizations in 66% of long afterhyperpolarizing (LAH) neurons without significant desensitization. Twenty-one percent of tonic neurons and 24% of LAH neurons responded to the NK(3) agonist senktide but did not respond to SP, indicating SP did not activate NK(3) receptors at this concentration. All effects of SP were abolished by the selective NK(1) receptor antagonist, SR140333, but not by the selective NK(3) receptor antagonist, SR142801, suggesting that exogenous SP activated a receptor with NK(1) pharmacology. No dye-filled LAH neuron and only 50% of tonic neurons responding to SP expressed NK(1) receptor immunoreactivity (NK(1)-IR). All neurons responding to SP had SP immunoreactive fibers within one cell diameter, indicating good spatial matching between SP release sites and target neurons. These results indicate that SP may act via a receptor with NK(1)-like pharmacology that has a C terminus not recognized by antibodies to the intracellular domain of the conventional NK(1) receptor. Inward currents evoked by SP acting on this NK(1)-like receptor or senktide acting through NK(3) receptors had identical current-voltage relationships. In LAH neurons, both agonists suppressed I(sAHP) without reducing I(AHP). Responses evoked by SP and senktide were resistant to PKC inhibitors, suggesting that the transduction mechanisms for the NK(1)-like receptor and the NK(3) receptor may be similar.
Jobling
P
P
Department of Anatomy and Histology and Centre for Neuroscience, Flinders University of South Australia, Adelaide, SA 5001, Australia. phillip.jobling@flinders.edu.au
Messenger
J P
JP
Gibbins
I L
IL
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001710:Biotin / Q000031:analogs & derivatives* / Q000032:analysis; D004396:Coloring Agents / Q000032:analysis; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D005728:Ganglia, Sympathetic / Q000166:cytology*; D006168:Guinea Pigs; D007091:Image Processing, Computer-Assisted; D007106:Immune Sera; D008297:Male; D008839:Microelectrodes; D009419:Nerve Tissue Proteins / Q000187:drug effects / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D018408:Patch-Clamp Techniques; D010446:Peptide Fragments / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D011812:Quinuclidines / Q000494:pharmacology; D018040:Receptors, Neurokinin-1 / Q000187:drug effects / Q000378:metabolism*; D018042:Receptors, Neurokinin-3 / Q000187:drug effects; D013373:Substance P / Q000031:analogs & derivatives / Q000494:pharmacology*; D017779:Sympathetic Fibers, Postganglionic / Q000378:metabolism; D015320:Tachykinins / Q000819:agonists / Q000378:metabolism*
D004396:Coloring Agents; D004791:Enzyme Inhibitors; D007106:Immune Sera; D009419:Nerve Tissue Proteins; D010446:Peptide Fragments; D010880:Piperidines; D011812:Quinuclidines; D018040:Receptors, Neurokinin-1; D018042:Receptors, Neurokinin-3; D015320:Tachykinins; C070614:neurobiotin; C054724:senktide; C085215:SR 140333; D013373:Substance P; D001710:Biotin; D011493:Protein Kinase C; C091554:SR 142801